Pierce Kristen
SEC insider (Form 3/4/5 filer). CIK 0002039649. Chief Development Officer at CERO THERAPEUTICS HOLDINGS, INC. (CERO). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Pierce Kristen has filed insider reports for
- CERO THERAPEUTICS HOLDINGS, INC. (CERO): Officer, Chief Development Officer
Pierce Kristen
CIK: 0002039649
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CERO THERAPEUTICS HOLDINGS, INC.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 7, 2026CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
1.6M shares- - May 30, 2025CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
154.8K shares- - Oct 1, 2024CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 7, 2026 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 1,612,099 | - | - | Direct |
| May 30, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 154,841 | - | - | Direct |
| Oct 1, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 200,000 | - | - | Direct |
1-3 of 3 transactions